期刊文献+

生物细胞的永生化和去永生化在细胞镇痛中的应用进展 被引量:1

Application and Development of Immortalization and Disimmortalization of Cells in Cellular Implantation for Pain Therapy
下载PDF
导出
摘要 慢性疼痛和晚期癌痛的治疗研究一直是生命科学的重要课题之一,传统的药物止痛有着诸多不可避免的缺陷。目前,细胞镇痛在动物实验研究方面获得了大量的资料和经验,虽然生物细胞的永生化可暂时解决镇痛细胞的来源和存活等问题,但因其潜在的致瘤性,限制了其推广应用。迄今,随着可诱导的Cre-LoxP重组酶系统在细胞去永生化中的应用,在镇痛细胞的来源、存活和安全性等方面取得了突破性进展,为细胞镇痛的临床应用奠定了基础。
出处 《国外医学(麻醉学与复苏分册)》 CAS 2004年第2期65-67,共3页 Foreign Medical Sciences(Anesthesilolgy and Resuscitation)
基金 国家自然科学基金资助项目(30170905)
  • 相关文献

参考文献21

  • 1Eaton MJ, Herman JP, Jullien N, et al. Immortalized chromaffin cells disimmortalized with Cre/Lox site-directed recombination for use in cell therapy for pain after partial nerve injury. Exp Neurol, 2002,175:49-60.
  • 2Sagen J, Pappas GD, Perlow MJ. Adrenal medullar transplants in the rat spinal cord reduce pain sensitivity. Brain Res, 1986,384:189-194.
  • 3Anton M, Graham FL. Site-specific recombination mediated by an adenovirus vector expressing the Crc recombinase protein: a molecular switch for control of gene expression. J Virol, 1995,69:4600-4606.
  • 4Berghella L, De Angelis L, Coletta M, et al. Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene. Hum Gene Ther, 1999,10:1607-1617.
  • 5Kobayashi NT, Fujiwara KA, Westerman Y, et al. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science,2000,287:1258-1262.
  • 6Lakso M, Sauer B, Mosinger B, et al. Targeted oncogene activation by sitespecific recombination in transgenic mice. Proc Natl Acad Sci USA, 1992,89: 6232-6236.
  • 7Shockett PE, Schatz DG. Diverse strategies for tetracycline-regulated inducible gene expression. Proc Natl Acad Sci USA, 1996,93:5173-5176.
  • 8Brocard J, Warot X, Wendling O, et al. Spatio-temporally controlled sitespecific somatic mutagenesis in the mouse. Proc Natl Aced Sci USA, 1997,94:14559-14563.
  • 9Kellendonk C, Tronche F, Casanova E, et al. Inducible site-specific recombination in the brain. J Mol Biol, 1999,285:175-182.
  • 10Russ AP, Friedel C, Ggrez M, et al. Self-deleting retrovirus vector for gene therapy. J Virol, 1996,70: 4927-4932.

同被引文献16

  • 1Eaton MJ. Emerging cell and molecular strategies for the study and treatment of painful peripheral neuropathies. JPNS, 2000, 5: 60 ~ 73.
  • 2Unsicker K. The trophic cocktail made by adrenal chromaffin cells. Exp Neurology, 1993,123 : 167~ 173.
  • 3Czech KA, Ryan JW, Sagen J, et al. The influence of xenotransplant immunogenicity and immunosuppression on host MHC expression in the rat CNS. Exp Neurology, 1997, 147: 66~83.
  • 4Russ AP, Friedel C, Ggrez M, et al. Self-deleting retrovirus vector for gene therapy. J Virol, 1996,70: 4927 ~ 4932.
  • 5Eaton M J, Heman JP, Julien N, et al. Immortalized chromaffin cells disimmortalized with Cre-Lox site-directed recombination for use in cell therapy for pain after nerve injury. Exp Neurol, 2002, 175: 49 ~ 60.
  • 6Yao MZ, Gu JF, Wang JH, et al. Interleukin-2gene therapy of chronic neuropathic pain. Neuroscience, 2002,112:409 ~416.
  • 7Goss JR, Mata M, Goins WF, et al. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. GENE THERAPY, 2001, 8 :551 ~ 556.
  • 8Eaton MJ, Blits B, Ruitenberg MJ, et al. Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV)vector-mediated over-expression of BDNF in the rat spinal cord., GENE THERAPY ,2002, 9 :1387 ~ 1395.
  • 9Rydh-Rinder M, Berge OG, Hokfelt T. Antinocicepptive after intrathecal administration of phosphodiester-, 2 '-O-allyl-, and C-5-propynemodified antisense oligodeoxynucleotides targeting the NMDARI subunit in mouse. BRMBR, 2001,86:23 ~ 33.
  • 10Krichevsky AM, Kosik KS. RNAi functions in cultured mammalian neurons. Proc Natl Acad Sci USA, 2002, 99: 11926~11929.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部